Director, Clinical Operations EU & Partner Liaison
17 hours ago
Oxford
Job Title: Director, Clinical Operations EU & Partner Liaison Department: Clinical Operations Location: Oxford, UK About Summit: Ivonescimab, known as SMT112, is a novel, potential first-in-class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD-1 wit...